Lead sponsor
Radboud University Medical Center
16 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 6, 2026.
16
Trials led
1
Ongoing
2,056
Total enrollment
15
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 1/2
3
Phase 2
2
Phase 2/3
1
Not applicable
9
Trials by status
Not yet recruiting
1
Completed
5
Terminated
1
Unknown
9
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Visualizing Beta Cells in Patients With a History of Gestational DiabetesBMI 17-30not applicableUnknown24